85 related articles for article (PubMed ID: 27654265)
21. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
22. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
23. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.
Meva J; Chaudhary RK; Bhaduri D; Bhatia M; Hatti S; Ba R
Int J Gynecol Cancer; 2013 Jul; 23(6):1071-7. PubMed ID: 23792602
[TBL] [Abstract][Full Text] [Related]
24. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
25. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72-kDa metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Romanini C; Biagini G
Gynecol Oncol; 1996 Apr; 61(1):83-9. PubMed ID: 8626123
[TBL] [Abstract][Full Text] [Related]
26. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of stage IB cervical cancer.
Ungár L; Pálfalvi L; Tarnai L; Nechushkina V; Lintner B; Novák Z;
Int J Gynecol Cancer; 2012 Nov; 22(9):1597-603. PubMed ID: 23051962
[TBL] [Abstract][Full Text] [Related]
28. The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.
Lai R; Dang CT; Malkin MG; Abrey LE
Cancer; 2004 Aug; 101(4):810-6. PubMed ID: 15305414
[TBL] [Abstract][Full Text] [Related]
29. Capecitabine therapy of central nervous system metastases from breast cancer.
Ekenel M; Hormigo AM; Peak S; Deangelis LM; Abrey LE
J Neurooncol; 2007 Nov; 85(2):223-7. PubMed ID: 17611719
[TBL] [Abstract][Full Text] [Related]
30. Ovarian metastasis in stage IB and II cervical adenocarcinoma.
Natsume N; Aoki Y; Kase H; Kashima K; Sugaya S; Tanaka K
Gynecol Oncol; 1999 Aug; 74(2):255-8. PubMed ID: 10419741
[TBL] [Abstract][Full Text] [Related]
31. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
32. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
33. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
34. The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients.
Miura S; Kaira K; Kaira R; Akamatsu H; Ono A; Shukuya T; Tsuya A; Nakamura Y; Kenmotsu H; Naito T; Murakami H; Takahashi T; Endo M; Yamamoto N
Invest New Drugs; 2015 Jun; 33(3):755-60. PubMed ID: 25846908
[TBL] [Abstract][Full Text] [Related]
35. Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.
Segaert A; Traen K; Van Trappen P; Peeters F; Leunen K; Goffin F; Vergote I
Int J Gynecol Cancer; 2015 Nov; 25(9):1690-6. PubMed ID: 26495762
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
38. Tumor distribution and survival in six patients with brain metastases from cervical carcinoma.
Mahmoud-Ahmed AS; Suh JH; Barnett GH; Webster KD; Kennedy AW
Gynecol Oncol; 2001 May; 81(2):196-200. PubMed ID: 11330949
[TBL] [Abstract][Full Text] [Related]
39. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
40. Location of Sentinel Lymph Node in Cervical Carcinoma and Factors Associated With Unilateral Detection.
Wuntakal R; Papadopoulos AJ; Montalto SA; Perovic M; Coutts M; Devaja O
Int J Gynecol Cancer; 2015 Nov; 25(9):1663-8. PubMed ID: 26270124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
